NCT00002007View on ClinicalTrials.gov

A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV InfectionsCytopenias
Interventions
DRUG

Zidovudine

DRUG

Sargramostim

Trial Locations (1)

20892

Natl Cancer Institute, Bethesda

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00002007 - A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia | Biotech Hunter | Biotech Hunter